Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Peer Reviewed & Journal

Peer Reviewed & Journal

49 results

Sort 49 results by:

Filter Applied. Clear All

Latest Posts

October 6, 2026 A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Inside The Government Decision That Opened Up Abortion Pill Floodgates Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Reset All Filters
Peer Reviewed & Journal

The Origins and Proliferation of Unfounded Comparisons Regarding the Safety of Mifepristone

This paper systematically examines, and refutes, claims to the effect that the abortion drug mifepristone is as safe as Tylenol…

Cameron Louttit, Ph.D.
May 27, 2025
Please login to bookmark Close
Peer Reviewed & Journal

Is relief the most common reaction to abortion? Self-assessed intensity of emotions attributed to abortion in a national sample of women aged 41 to 45

It is often reported that the most prominent emotion following abortion is relief, a claim that primarily rests on two…

Peer Reviewed & Journal

Suicide risks associated with pregnancy outcomes: a national cross-sectional survey of American females 41–45 years of age

Many studies have linked abortion to a higher risk of suicide. According to one hypothesis, this association is entirely incidental…

CLI logo
Peer Reviewed & Journal

Comparative Acuity of Emergency Department Visits Following Pregnancy Outcomes Among Medicaid Eligible Women, 2004-2015

Consistent with national trends for ED visits, both the number and acuity of ED visits following pregnancy outcomes are increasing.…

CLI logo
Peer Reviewed & Journal

First Pregnancy Abortion or Natural Pregnancy Loss: A Cohort Study of Mental Health Services Utilization

While both induced abortion and natural pregnancy loss have been associated with subsequent mental health problems, population-based studies directly comparing…

Peer Reviewed & Journal

Is Induced Abortion Evidence-Based Medical Practice?

CLI Director of Data Analytics Dr. James Studnicki and Director of Medical Affairs Dr. Ingrid Skop recently published their paper…

CLI logo
Peer Reviewed & Journal

Welcomed Pregnancies: Characteristics and Patterns of Adjusting to Unwanted, Unplanned, Untimely or Otherwise Difficult Pregnancies

In this study, women dealing with pregnancies that were problematic and who did not choose abortion experienced rapid improvements in…

CLI logo
Peer Reviewed & Journal

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

CLI's VP of Medical Affairs Ingrid Skop, together with Calum Miller, MD, and Kevin Duffy, MPH, recently published an article…

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image